Serial Number | 98165909 |
Word Mark | CELLREJUV |
Filing Date | Tuesday, September 5, 2023 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Wednesday, August 21, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Nutritional supplements |
Pseudo Mark | CELL REJUVENATION |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, September 5, 2023 |
Primary Code | 005 |
First Use Anywhere Date | Tuesday, October 17, 2023 |
First Use In Commerce Date | Friday, December 29, 2023 |
Party Name | NOT AVAILABLE |
Party Type | 10 - Original Applicant |
Legal Entity Type | 01 - Individual |
Address | Aldie, VA 20105 |
Event Date | Event Description |
Friday, November 17, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Wednesday, September 6, 2023 | NEW APPLICATION ENTERED |
Monday, March 4, 2024 | TEAS AMENDMENT OF USE RECEIVED |
Monday, March 4, 2024 | USE AMENDMENT FILED |
Monday, March 4, 2024 | AMENDMENT TO USE PROCESSING COMPLETE |
Wednesday, May 1, 2024 | USE AMENDMENT ACCEPTED |
Wednesday, May 1, 2024 | NON-FINAL ACTION WRITTEN |
Wednesday, May 1, 2024 | NON-FINAL ACTION E-MAILED |
Wednesday, August 21, 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Wednesday, August 21, 2024 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Wednesday, May 1, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Wednesday, May 1, 2024 | ASSIGNED TO EXAMINER |
Thursday, May 2, 2024 | NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED |